All eyes on CVM after CEO, Geert Kersten tweeted up a s storm Sunday expressing excitement about imminent data from their Phase 3 cancer trial.
In addition to CVM I will be watching the other biotech's on Biotech Hitman "journalist", Adam [sic} Fuckstein's fab 50 short list.
I have picked AMPE in the past so I am most inclined to keep a close eye on it.
TRIB - Watching this for some continuation moves after a big spike on Friday.
AVXL - Watching this former pick after I was alerted to its move above the .61 fibonacci level.
CDMO - Is new to my watch list. MACD is curling up and price tested the 1 level on my fibonacci extension . Also the POC is in close proximity to the current price which should make this a low risk entry.
Also watching: TKAT, TDMI and GME, AMC for scalp trades today.